Pancreatic Cancer Research

ResearcherDazhou Central HospitalNo recent work listed

Mingzhong Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0004-2736-3028; OpenAlex author ID A5000021357. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. lncRNA Differentiation Antagonizing Nonprotein Coding RNA Overexpression Accelerates Progression and Indicates Poor Prognosis in Pancreatic Ductal Adenocarcino… Co-author DOI 10.2147/ott.s432292↗
  2. Restore of miR-541 resensitizes pancreatic cancer cells to gemcitabine-induced apoptosis through suppression of HAX-1 Last author DOI 10.21203/rs.3.rs-41511/v1↗
  3. lncRNA differentiation antagonizing nonprotein coding RNA overexpression accelerates progression and indicates poor prognosis in pancreatic ductal adenocarcino… Co-author DOI 10.2147/ott.s167065↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lei Ting Chen · 2 shared papers, 2018–2023 · strength 0.30
  2. Jun Zhang · 1 shared paper, 2023 · strength 0.20
  3. Zhongqiu Yang · 1 shared paper, 2020 · strength 0.11
  4. Hong Liu · 1 shared paper, 2020 · strength 0.11
  5. Jun Zhang · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.